Summary
GlobalData's new report, "Diabetes Care Devices Global Market Briefing to 2016" provides key data, information and analysis on the global diabetes care devices market. The report provides market landscape, competitive landscape and market trends information the diabetes care devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key segments covered include glucose monitoring devices (blood glucose test strips, blood glucose meters, lancets), and insulin delivery devices (insulin pens, insulin syringes, insulin pumps).
- Annualized global market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market drivers, and restraints by each category within diabetes care devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Roche, LifeScan, Novo Nordisk, Eli Lilly, Bayer, and Medtronic.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next being thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global diabetes care devices market and the factors shaping it.
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Diabetes – An Overview 6
2.1 Epidemiology 6
3 Device Care Devices – An Overview 8
3.1 Glucose Monitoring Devices 8
3.2 Insulin Delivery Devices 9
4 Global Diabetes Care Devices: Market Characterization 10
4.1 Diabetes Care Devices Market, Global, Revenue ($bn), Historic, 2002-2009 10
4.2 Diabetes Care Devices Market, Global, Revenue ($bn), Forecast, 2009-2016 11
4.3 Glucose Monitoring Devices Market, Global, Revenue ($bn), Historic, 2002–2009 12
4.4 Glucose Monitoring Devices Market, Global, Volume (Units), Historic, 2002–2009 13
4.5 Glucose Monitoring Devices Market, Global, Revenue ($bn), Forecast, 2009–2016 14
4.6 Glucose Monitoring Devices Market, Global, Volume (Units), Forecast, 2009–2016 15
4.7 Insulin Delivery Devices Market, Global, Revenue ($bn), Historic, 2002–2009 16
4.8 Insulin Delivery Devices Market, Global, Volume (Units), Historic, 2002–2009 17
4.9 Insulin Delivery Devices Market, Global Revenue ($bn), Forecast, 2009-2016 18
4.10 Insulin Delivery Devices Market, Global, Volume (Units), Forecast, 2009–20016 19
4.11 Diabetes Care Devices, Market Drivers 20
4.11.1 Patient Convenience to be a Major Factor in Choice of Diabetes Care Devices and will Drive the Market in the Near Future 20
4.11.2 Advances in the Technology and Introduction of New Generation Devices to Boost Sales of the Diabetes Care Devices 20
4.11.3 The Advantages Offered by Insulin Pumps to Niche Patient Groups is Expected to Drive the Insulin Pumps Market 21
4.11.4 Increasing Demand for Glucose Monitoring in Home Care to Drive Growth 21
4.12 Diabetes Care Devices, Market Restraints 21
4.12.1 Low Diagnosis Rate to Restrain Growth of Diabetes Care Devices Market 21
4.12.2 Cultural Preferences among the Elderly for Traditional Remedies may Negatively Effect Diabetes Care Devices Markets 21
4.12.3 Local Companies to Compete with Big Players in Terms of Distribution and Price 22
4.12.4 Regular Maintenance, Risk of Infection and Associated Pain Raise Patient Concerns about the Adoption of Diabetes Care Devices 22
4.12.5 Recent Product Recalls by the US Food and Drug Administration may Lead to Low Prescription Rates in the Future 22
4.12.6 High Cost to be a Major Deterrent towards Widespread Adoption of Insulin Pumps 23
5 US Diabetes Care Devices: Market Characterization 24
5.1 Diabetes Care Devices Market, US, Revenue ($m), Historic, 2002-2009 24
5.2 Diabetes Care Devices Market, US, Volume (units), Historic, 2002-2009 25
5.3 Diabetes Care Devices Market, US, Revenue ($m), Forecast, 2009-2016 26
5.4 Diabetes Care Devices Market, US, Volume (Units), Forecast, 2009-2016 27
6 Diabetes Care Devices Market, Competitive Assessment 28
6.1 Glucose Monitoring Devices Market, Global, Key Company Shares 29
6.2 Insulin Delivery Devices, Global, Key Company Shares 30
6.3 Diabetes Care Devices Market: Key Market Participants 31
6.3.1 F. Hoffmann-La Roche Ltd. 32
6.3.2 LifeScan, Inc. 33
6.3.3 Novo Nordisk A/S 34
6.3.4 Eli Lilly and Company 35
6.3.5 Bayer HealthCare AG 36
6.3.6 Medtronic, Inc. 37
7 Diabetes Care Devices Market, Pipeline Assessment 38
7.1 Diabetes Care Devices, Pipeline Products, by Segment 38
7.2 Profiles of Promising Diabetes Care Devices Under Clinical Development 39
7.2.1 Non Invasive Glucose Monitoring Devices 39
7.2.2 Insulin Pumps 40
7.2.3 Glucose Monitoring Devices 41
8 Appendix 44
8.1 Research Methodology 44
8.2 Secondary Research 45
8.3 Primary Research 45
8.4 Models 45
8.5 Forecasts 46
8.6 Expert Panels 46
8.7 GlobalData Consulting 46
8.8 Contact Us 46
8.9 Disclaimer 46
1.1 List of Tables
Table 1: Diabetes, Major Countries, Estimated Prevalence, 2010 and 2030 7
Table 2: Diabetes Care Devices Market, Global, Revenue ($bn), 2002–2009 10
Table 3: Diabetes Care Devices Market, Global, Revenue ($bn), 2009–2016 11
Table 4: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2002–2009 12
Table 5: Glucose Monitoring Devices Market, Global, Volume (million), 2002–2009 13
Table 6: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2009–2016 14
Table 7: Glucose Monitoring Devices Market, Global, Volume (million), 2009–2016 15
Table 8: Insulin Delivery Devices Market, Global, Revenue ($bn), 2002–2009 16
Table 9: Insulin Delivery Devices Market, Global, Volume (million), 2002–2009 17
Table 10: Insulin Delivery Devices Market, Global, Revenue ($bn), 2009–2016 18
Table 11: Insulin Delivery Devices Market, Global, Volume (million), 2009–2016 19
Table 12: Diabetes Care Devices Market US, Revenue ($m), 2002–2009 24
Table 13: Diabetes Care Devices Market, US, Volume (millions), 2002–2009 25
Table 14: Diabetes Care Devices Market, US, Revenue ($m), 2009–2016 26
Table 15: Diabetes Care Devices Market, US, Volume (Millions), 2009–2016 27
Table 16: Diabetes Care Devices Market, Global, Revenue ($m), 2009 28
Table 17: Glucose Monitoring Devices Market, Global, Revenue ($m), 2009 29
Table 18: Insulin Delivery Devices Market, Global, Revenue ($m), 2009 30
Table 19: Hoffmann-La Roche Ltd., Marketed Products, 2010 32
Table 20: Hoffmann-La Roche Ltd., Pipeline Products, 2010 32
Table 21: LifeScan, Inc. Marketed Products, 2010 33
Table 22: LifeScan, Inc. Pipeline Products, 2010 33
Table 23: Novo Nordisk A/S, Marketed Products, 2010 34
Table 24: Novo Nordisk A/S, Pipeline Products, 2010 34
Table 25: Eli Lilly and Company, Marketed Products, 2010 35
Table 26: Bayer HealthCare AG, Pipeline Products, 2010 36
Table 27: Medtronic, Inc. Marketed Products, 2010 37
Table 28: Medtronic, Inc. Pipeline Products, 2010 37
Table 29: Global Diabetes Care Devices Market, Pipeline, 2010 38
Table 30: EyeSense Blood Glucose Measurement Device, Product Status, 2010 39
Table 31: Easy Check Breathe Glucose Detection System, Product Status, 2010 39
Table 32: SENTRIS-100, Product Status, 2010 40
Table 33: Artificial Pancreas System, Product Status, 2010 40
Table 34: Disposable Insulin Pump System, Product Status, 2010 40
Table 35: Integrated Symbiq/EndoTool System, Product Status, 2010 41
Table 36: Paradigm Veo System, Product Status, 2010 41
Table 37: ACCU-Chek Inform II with RALS Plus Data Management System, Product Status, 2010 41
Table 38: Pin-SCAN-Non invasive Glucose Meter, Product Status, 2010 42
Table 39: Affinity-based Turbidity Sensor-Glucose Monitoring, Product Status, 2010 42
Table 40: RFID Glucose-Sensing Microchip, Product Status, 2010 42
Table 41: Silicon Micro-Needle, Product Status, 2010 43
1.2 List of Figures
Figure 1: Diabetes, Major Countries, Estimated Prevalence, 2010 and 2030 6
Figure 2: Diabetes Care Devices, Market Segments 8
Figure 3: Diabetes Care Devices Market, Global, Revenue ($bn), 2002–2009 10
Figure 4: Diabetes Care Devices Market, Global, Revenue ($bn), 2009–2016 11
Figure 5: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2002–2009 12
Figure 6: Glucose Monitoring Devices Market, Global, Volume (million), 2002–2009 13
Figure 7: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2009–2016 14
Figure 8: Glucose Monitoring Devices Market, Global, Volume (million), 2009–2016 15
Figure 9: Insulin Delivery Devices Market, Global, Revenue ($bn), 2002–2009 16
Figure 10: Insulin Delivery Devices Market, Global, Volume (million), 2002–2009 17
Figure 11: Insulin Delivery Devices Market, Global, Revenue ($bn), 2009–2016 18
Figure 12: Insulin Delivery Devices Market, Global, Volume (million), 2009–2016 19
Figure 13: Diabetes Care Devices Market US, Revenue ($m), 2002–2009 24
Figure 14: Diabetes Care Devices Market, US, Volume (millions), 2002–2009 25
Figure 15: Diabetes Care Devices Market, US, Revenue ($m), 2009–2016 26
Figure 16: Diabetes Care Devices Market, US, Volume (Millions), 2009–2016 27
Figure 17: Diabetes Care Devices Market, Global, Key Company Share, %, 2009 28
Figure 18: Glucose Monitoring Devices Market, Global, Key Company Share, %, 2009 29
Figure 19: Insulin Delivery Devices Market, Global, Key Company Share, %, 2009 30
Figure 20: Diabetes Care Devices Market, Presence of Key Market Participants by Segment, 2010 31
Figure 21: Global Diabetes Care Devices Market, Pipeline, 2010 38
Companies mentioned
F. Hoffmann-La Roche Ltd
LifeScan, Inc.
Novo Nordisk A/S
Eli Lilly and Company
Bayer HealthCare AG
Medtronic, Inc.
Showing posts with label diabetes. Show all posts
Showing posts with label diabetes. Show all posts
Sunday, October 17, 2010
Friday, October 15, 2010
Disease Management: Diabetes Natural Remedies
Disease management diabetes is about the management of the diabetes disease and how natural supplements may help you to become symptom free.
Diabetes as a disease has been known for thousands of years. And in that time, diabetes disease management by physicians found and used various natural remedies, which often have been overlooked today—particularly in today's era of expensive prescription drugs.
Here is an extract from a site with a focus on disease management of diabetes:
------------
Diabetes as a disease has been known for thousands of years. And in that time, diabetes disease management by physicians found and used various natural remedies, which often have been overlooked today—particularly in today's era of expensive prescription drugs.
Here is an extract from a site with a focus on disease management of diabetes:
------------
"Do You or a Loved One Have Diabetes?
"Want To Discover "SECRETS" about Vitamins and Minerals that most Doctors Can't or Won't Reveal To Their Patients with Diabetes?
"Would You Like To Learn More about Vitamins that may Help Your Body To Become "SYMPTOM" Free?
"If you or a loved one has type 2 diabetes, also called adult onset diabetes, insulinemia, and diabetes mellitus, the next few minutes you spend at this site could be the most important time you spend on the internet this ENTIRE YEAR!"
Gestational Diabetes: Careful Control Needed in Gestational Diabetes
Gestational diabetes occurs when the pregnant mother's body does not maintain normal blood sugar levels but, instead, the mother's blood sugar rises to and remains at above-normal levels. Because of the long-term risk to the unborn baby, careful control of the mother's blood sugar levels is critical.

Here is some information on gestational diabetes:
Here is some information on gestational diabetes:
Diabetic Pregnant Women - Gestational Diabetes
Gestational diabetes affects approximately 3 to 5 percent of all pregnant women in the United States. This article addresses issues such as diet, exercise, blood sugar level and general medical care of women with gestational diabetes.
Diabetes is a disease where the body uses food improperly. The body gets its main energy source from glucose or from a breakdown of complex carbohydrates such as starches. Once sugar and starches are digested, they enter the blood stream in the form of glucose. Insulin assists the body in getting the glucose from the blood stream to the muscles and other body tissues. The pancreas is where insulin is manufactured. Glucose cannot get into the body cells without insulin. Instead, glucose accumulates in the blood and is excreted into the urine through the kidneys.
Women with gestational diabetes have plenty of insulin. The problem is that the insulin is partly blocked by hormones made in the placenta. This is called insulin resistance. In women without gestational diabetes, the pancreas makes enough insulin to overcome the insulin resistance. But when the pancreas makes all the insulin it can and it still cannot overcome the effect of the placenta's hormones, that woman has gestational diabetes.
Factors associated with an increased risk of gestational diabetes are obesity, diabetes in the family, a stillbirth, or a child with a birth defect. Studies have shown that women older than 25 are also at greater risk. The Council on Diabetes in Pregnancy recommends that all pregnant women be screened for this disease. One of the most common screening methods is the 50-gram glucose screening test.
The key to preventing complications is control of blood sugar levels immediately after the diagnosis of gestational diabetes. A comforting fact is that gestational diabetes does not cause birth defects. But many babies are born much larger than average. The baby can grow too large for a vaginal birth and a cesarean section delivery is necessary. In some cases, the baby is born with hypoglycemia. In this case, the baby will be given glucose intravenously. These two examples are manageable and preventable. The key is careful control of blood sugar levels in the mother immediately after the diagnosis of gestational diabetes.
An important component in caring for gestational diabetes is a strict diet. There is a wide assortment of literature that details dietary guidelines for women with gestational diabetes. Her health care practitioner will teach her how to measure her blood glucose level at home. Additionally, she may have to check her urine for ketones (these are by-products of the breakdown of fat). Ketones may be found in the blood and urine as a result of inadequate insulin.
It is very unlikely that the baby will have diabetes. However, the child may be at risk for Type II diabetes
. Other problems such as hypoglycemia and jaundice may also occur.
More than likely, gestational diabetes goes away immediately after delivery. But these women are at risk of developing it in future pregnancies. Make sure to have screening tests during subsequent pregnancies in the first trimester.
Diabetes is a disease where the body uses food improperly. The body gets its main energy source from glucose or from a breakdown of complex carbohydrates such as starches. Once sugar and starches are digested, they enter the blood stream in the form of glucose. Insulin assists the body in getting the glucose from the blood stream to the muscles and other body tissues. The pancreas is where insulin is manufactured. Glucose cannot get into the body cells without insulin. Instead, glucose accumulates in the blood and is excreted into the urine through the kidneys.
Women with gestational diabetes have plenty of insulin. The problem is that the insulin is partly blocked by hormones made in the placenta. This is called insulin resistance. In women without gestational diabetes, the pancreas makes enough insulin to overcome the insulin resistance. But when the pancreas makes all the insulin it can and it still cannot overcome the effect of the placenta's hormones, that woman has gestational diabetes.
Factors associated with an increased risk of gestational diabetes are obesity, diabetes in the family, a stillbirth, or a child with a birth defect. Studies have shown that women older than 25 are also at greater risk. The Council on Diabetes in Pregnancy recommends that all pregnant women be screened for this disease. One of the most common screening methods is the 50-gram glucose screening test.
The key to preventing complications is control of blood sugar levels immediately after the diagnosis of gestational diabetes. A comforting fact is that gestational diabetes does not cause birth defects. But many babies are born much larger than average. The baby can grow too large for a vaginal birth and a cesarean section delivery is necessary. In some cases, the baby is born with hypoglycemia. In this case, the baby will be given glucose intravenously. These two examples are manageable and preventable. The key is careful control of blood sugar levels in the mother immediately after the diagnosis of gestational diabetes.
An important component in caring for gestational diabetes is a strict diet. There is a wide assortment of literature that details dietary guidelines for women with gestational diabetes. Her health care practitioner will teach her how to measure her blood glucose level at home. Additionally, she may have to check her urine for ketones (these are by-products of the breakdown of fat). Ketones may be found in the blood and urine as a result of inadequate insulin.
It is very unlikely that the baby will have diabetes. However, the child may be at risk for Type II diabetes
More than likely, gestational diabetes goes away immediately after delivery. But these women are at risk of developing it in future pregnancies. Make sure to have screening tests during subsequent pregnancies in the first trimester.
Saturday, October 9, 2010
Is managing diabetes a full time job?
If only I had nothing else to do... Right? Wrong - but anyways.
I sometimes feel like there are so many things that we deal with that sometimes my diabetes takes a back seat and I don't give it the attention I need to in order to achieve better control. I mean, life gets busy sometimes!!!
I often think that managing diabetes can be a full time job, and at times it can be. But looking at how typical management is done, it's kind of weird. Managing diabetes is not a "task" that you can focus on and "get it done", but rather requires multiple mental "visits" through the course of a day.
I think my biggest problem is maintaining a consistant level of diligence through the course of the day. I might be very motivated at one point of the day, but I have problems maintaining that level of motivation while navigating the course that unravels for the rest of the day.
So, if I didn't work, or do anything else at all, would I be able to manage my diabetes better? I don't think so - just because I don't think any of us can maintain that focus all day every day!
The puzzle is figuring out how to balance everything when taken together. I think that diabetes can be just a small mental part of our normal thought process during the day. Similar to driving - I'm still very careful when driving, but for the most part it is somewhat unconcious. Something I've been doing for so long that it does not require 100% focus like it did when I first drove. Maybe diabetes is a bit like that? Some situations and circumstances requiring more focus and attention, but for the most part occupying a small amount of mental resources...??
I sometimes feel like there are so many things that we deal with that sometimes my diabetes takes a back seat and I don't give it the attention I need to in order to achieve better control. I mean, life gets busy sometimes!!!
I often think that managing diabetes can be a full time job, and at times it can be. But looking at how typical management is done, it's kind of weird. Managing diabetes is not a "task" that you can focus on and "get it done", but rather requires multiple mental "visits" through the course of a day.
I think my biggest problem is maintaining a consistant level of diligence through the course of the day. I might be very motivated at one point of the day, but I have problems maintaining that level of motivation while navigating the course that unravels for the rest of the day.
So, if I didn't work, or do anything else at all, would I be able to manage my diabetes better? I don't think so - just because I don't think any of us can maintain that focus all day every day!
The puzzle is figuring out how to balance everything when taken together. I think that diabetes can be just a small mental part of our normal thought process during the day. Similar to driving - I'm still very careful when driving, but for the most part it is somewhat unconcious. Something I've been doing for so long that it does not require 100% focus like it did when I first drove. Maybe diabetes is a bit like that? Some situations and circumstances requiring more focus and attention, but for the most part occupying a small amount of mental resources...??
Apple Cider Vinegar: Blood Glucose Levels Reduced
Apple cider vinegar can help blunt the rise in blood glucose levels after a meal that is high in carbohydrates, according to study published in Diabetes Care. The study was performed by Carol S. Johnston, PHD, et al.
Apple cider vinegar and blood glucose levels are linked in the reported study. The researchers studied both diabetic subjects (with type 2 diabetes) and non-diabetic subjects (either resistant to insulin or sensitive to insulin).
The study protocol involved having subjects who were fasting consume either an apple cider vinegar and water mixture or a placebo mixture, based on random assignment of subjects. The apple cider vinegar mixture used to test for effects on blood glucose consisted of 20 grams [approximately 1 1/2 tablespoons] of apple cider vinegar, 40 grams of water, and 1 teaspoon of saccharine.
Then, after a delay of two minutes, the subjects ate a test meal that consisted of a white-flour bagel, with butter, and orange juice. The test meal contained a total of 87 grams of carbohydrates.
The apple cider vinegar researchers took the subjects' fasting blood samples, and then took blood samples at 30 minute and 60 minute points after the test meal. Blood glucose levels and insulin levels in these blood samples were analyzed. The researchers estimated whole-body insulin sensitivity of subjects during the 60-minute period after the test meal, assigning a composite score to each subject.
A week later, the subjects were switched between groups for a cross-over test.
Results of the apple cider vinegar blood glucose study: Subjects with diabetes had elevated fasting blood glucose levels of about 55 percent. Subjects having type 2 diabetes or insulin resistance had elevated fasting insulin concentrations of 95 – 115 percent, as compared to control group subjects.
Drinking the apple cider vinegar mixture caused the insulin-resistant subjects' whole-body insulin sensitivity to increase during the 60 minute period after the test meal (34 percent, at significance level 0.01) and caused a lesser rise among type-2 diabetic subjects (19 percent, at the 0.07 significance level).
Apple cider vinegar reduced the fluctuations in insulin significantly in control subjects after the test meal and reduced the fluctuations in both glucose and insulin in insulin-resistant subjects.
Source: "Vinegar Improves Insulin Sensitivity to a High-Carbohydrate Meal in Subjects With Insulin Resistance or Type 2 Diabetes" at http://care.diabetesjournals.org/cgi/content/full/27/1/281
Apple cider vinegar and blood glucose levels are linked in the reported study. The researchers studied both diabetic subjects (with type 2 diabetes) and non-diabetic subjects (either resistant to insulin or sensitive to insulin).
The study protocol involved having subjects who were fasting consume either an apple cider vinegar and water mixture or a placebo mixture, based on random assignment of subjects. The apple cider vinegar mixture used to test for effects on blood glucose consisted of 20 grams [approximately 1 1/2 tablespoons] of apple cider vinegar, 40 grams of water, and 1 teaspoon of saccharine.
Then, after a delay of two minutes, the subjects ate a test meal that consisted of a white-flour bagel, with butter, and orange juice. The test meal contained a total of 87 grams of carbohydrates.
The apple cider vinegar researchers took the subjects' fasting blood samples, and then took blood samples at 30 minute and 60 minute points after the test meal. Blood glucose levels and insulin levels in these blood samples were analyzed. The researchers estimated whole-body insulin sensitivity of subjects during the 60-minute period after the test meal, assigning a composite score to each subject.
A week later, the subjects were switched between groups for a cross-over test.
Results of the apple cider vinegar blood glucose study: Subjects with diabetes had elevated fasting blood glucose levels of about 55 percent. Subjects having type 2 diabetes or insulin resistance had elevated fasting insulin concentrations of 95 – 115 percent, as compared to control group subjects.
Drinking the apple cider vinegar mixture caused the insulin-resistant subjects' whole-body insulin sensitivity to increase during the 60 minute period after the test meal (34 percent, at significance level 0.01) and caused a lesser rise among type-2 diabetic subjects (19 percent, at the 0.07 significance level).
Apple cider vinegar reduced the fluctuations in insulin significantly in control subjects after the test meal and reduced the fluctuations in both glucose and insulin in insulin-resistant subjects.
Source: "Vinegar Improves Insulin Sensitivity to a High-Carbohydrate Meal in Subjects With Insulin Resistance or Type 2 Diabetes" at http://care.diabetesjournals.org/cgi/content/full/27/1/281
Subscribe to:
Posts (Atom)



